Boston University Clinical and Translational Science Institute
Boston University Clinical and Translational Science Institute
批准号:
9084905
负责人:
Darrell N. Kotton
金额:
$40.77万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-13 至 2019-03-31
关键词:
AddressAdoptedAffinityAreaBasic ScienceBiologicalBiomedical EngineeringBiomedical ResearchBone RegenerationBostonCardiologyClinicalClinical SciencesCollaborationsDentistryDermatologyDevelopmentDisciplineDoctor of PhilosophyDrug Delivery SystemsEducationEducational CurriculumEffectivenessEnvironmentFacultyFinancial SupportFloorFosteringFoundationsFramingham Heart StudyFundingFutureGastroenterologyGeriatricsGoalsHematologyHome environmentHousingIndustryInstitutesInstitutionIntentionInterdisciplinary StudyInternationalLaboratoriesLeadershipLearningMarketingMedicalMedicineMentorsMissionMolecular MedicineNational Research Service AwardsOrthopedicsOutcomePatientsPediatric OncologyPediatric Surgical ProceduresPerformancePeripheralPharmaceutical PreparationsPhenotypePlayPositioning AttributePostdoctoral FellowProcessProductivityProgram EvaluationPublicationsPulmonologyRegenerative MedicineResearchResearch PersonnelResearch TrainingResourcesRoleScienceScientistSecureShapesSickle CellStem Cell ResearchStem cellsStudentsStudy SubjectTechnologyTimeToxicity TestsTrainingTraining ProgramsTranslational ResearchUniversitiesVisionbasebench to bedsidecareercareer developmentcell bankdesignefficacy testingexperiencefoothuman diseaseinnovationinterdisciplinary approachinterestmedical schoolsmembermultidisciplinarypersonalized medicinephysical sciencepre-doctoralprogramsskillssuccessteachertooltranslational medicine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT: NRSA Training Core
The overarching concepts and goals of the Regenerative Medicine Training Program (RMTP
TL1) are to 1) provide an innovative, integrative and interdisciplinary training program for pre-
doctoral and post-doctoral trainees which will leverage a unique and internationally recognized
strength of BU, 2) establish an environment that facilitates translational team science
interactions with trainees, MD scientists and clinicians, thereby synergistically bridging research
strengths with interdisciplinary approaches in regenerative medicine, and 3) catapult BU into the
forefront of institutions that are producing scientists with the skills and expertise to fulfill a
current and future patient-based need for regenerative medicine. The objectives of our training
program also align precisely with the general Boston University CTSI (BU CTSI) goals and with
the strong emphasis on regenerative medicine at Boston University School of Medicine, as well
as to further the mission of NCATS of expediting personalized medicine and the discovery and
delivery of drugs to market. The RMTP will provide support for 3 pre-doctoral and 2 post-
doctoral trainees each year, totaling 27 pre-doctoral and 18 post-doctoral trainees supported for
the duration of the program, with each trainee participating for two years. Accepted trainees will
be outstanding students/postdocs and selected based on grades/productivity, quality of the
proposal, likely to pursue careers in academic regenerative medicine, highly motivated,
energetic, and well-prepared for the curriculum. The curriculum will be competency-based and
include rigorous training in didactic and laboratory based concepts and technology. An
extensive and individualized mentoring plan will be implemented for each trainee that will
included both scientific as well career development guidance. We fully anticipate that under the
vision of “todays trainees are the teachers of tomorrow”, the RMTP will generate a continual
influx of research and clinical leaders in the stem cell/regenerative medicine field who will make
significant contributions resulting in the realization of its full medical potential. We seek to retain
a major portion of our trainees, both in our own program and elsewhere, as investigators and
mentors in regenerative medicine. Success of the RMTP will be based on the ability to increase
the pipeline of well-trained scientists who continue their research in regenerative medicine, the
number and quality of their publications, and leadership positions they assume in both industry
and academic environments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a patient-specific organoid model of pulmonary fibrosis using iPSCs
-
批准号:10026360
-
项目类别:
-
资助金额:$50.86万
-
财政年份:2020
-
负责人:Darrell N. Kotton
-
依托单位:
Developing a patient-specific organoid model of pulmonary fibrosis using iPSCs
-
批准号:10318560
-
项目类别:
-
资助金额:$67.57万
-
财政年份:2020
-
负责人:Darrell N. Kotton
-
依托单位:
Developing a patient-specific organoid model of pulmonary fibrosis using iPSCs
-
批准号:10525231
-
项目类别:
-
资助金额:$65.39万
-
财政年份:2020
-
负责人:Darrell N. Kotton
-
依托单位:
Editing Alveolar Progenitor Cells for Correction of Monogenic Disease
-
批准号:10198995
-
项目类别:
-
资助金额:$125.83万
-
财政年份:2016
-
负责人:Darrell N. Kotton
-
依托单位:
Editing Alveolar Progenitor Cells for Correction of Monogenic Disease
-
批准号:10417109
-
项目类别:
-
资助金额:$124.62万
-
财政年份:2016
-
负责人:Darrell N. Kotton
-
依托单位:
NRSA Training Core
-
批准号:10615243
-
项目类别:
-
资助金额:$31.46万
-
财政年份:2015
-
负责人:Darrell N. Kotton
-
依托单位:
Epigenenomic and transcriptomic networks in normal and defective lung development
-
批准号:9144829
-
项目类别:
-
资助金额:$54.61万
-
财政年份:2015
-
负责人:Darrell N. Kotton
-
依托单位:
NRSA Training Core
-
批准号:10400208
-
项目类别:
-
资助金额:$47.87万
-
财政年份:2015
-
负责人:Darrell N. Kotton
-
依托单位:
Epigenenomic and transcriptomic networks in normal and defective lung development
-
批准号:8927909
-
项目类别:
-
资助金额:$57.77万
-
财政年份:2015
-
负责人:Darrell N. Kotton
-
依托单位:
Boston University Clinical and Translational Science Institute
-
批准号:9261614
-
项目类别:
-
资助金额:$56.88万
-
财政年份:2015
-
负责人:Darrell N. Kotton
-
依托单位:
Boston University Clinical and Translational Science Institute
-
批准号:9126634
-
项目类别:
-
资助金额:$56.84万
-
财政年份:2015
-
负责人:Darrell N. Kotton
-
依托单位:
NRSA Training Core
-
批准号:10086526
-
项目类别:
-
资助金额:$43.49万
-
财政年份:2015
-
负责人:Darrell N. Kotton
-
依托单位:
iPSC Modeling of the Role of NKX2-1 in Human Lung Development and Disease
-
批准号:9234044
-
项目类别:
-
资助金额:$40.93万
-
财政年份:2014
-
负责人:Darrell N. Kotton
-
依托单位:
iPSC Modeling of the Role of NKX2-1 in Human Lung Development and Disease
-
批准号:8829897
-
项目类别:
-
资助金额:$40.31万
-
财政年份:2014
-
负责人:Darrell N. Kotton
-
依托单位:
FASEB SRC on The Lung Epithelium in Health and Disease
-
批准号:8783118
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2014
-
负责人:Darrell N. Kotton
-
依托单位:
A National Resource for Lung disease-specific iPS cells
-
批准号:9261561
-
项目类别:
-
资助金额:$54.13万
-
财政年份:2014
-
负责人:Darrell N. Kotton
-
依托单位:
A National Resource for Lung disease-specific iPS cells
-
批准号:8758308
-
项目类别:
-
资助金额:$54.11万
-
财政年份:2014
-
负责人:Darrell N. Kotton
-
依托单位:
iPSC Modeling of the Role of NKX2-1 in Human Lung Development and Disease
-
批准号:8671729
-
项目类别:
-
资助金额:$40.93万
-
财政年份:2014
-
负责人:Darrell N. Kotton
-
依托单位:
A National Resource for Lung disease-specific iPS cells
-
批准号:9059173
-
项目类别:
-
资助金额:$54.13万
-
财政年份:2014
-
负责人:Darrell N. Kotton
-
依托单位:
A National Resource for Lung disease-specific iPS cells
-
批准号:8913259
-
项目类别:
-
资助金额:$53.32万
-
财政年份:2014
-
负责人:Darrell N. Kotton
-
依托单位:
海外基金